Objectives: There is solid evidence that risk for developing type 2 diabetes can be prevented by lifestyle interventions. However, there are few diabetes prevention programs available. Given the increasing prevalence of prediabetes, we sought to investigate if a commercial weight loss program with significant capacity could address this need. This study, conducted in Indianapolis, Indiana in 2014-16, investigated if (Weight Watchers-WW) could cost effectively achieve and sustain sufficient weight loss in persons with prediabetes to reduce diabetes risk for 24 months.
Methods:A previous, randomized controlled trial evaluated the effectiveness of the WW program in 225 persons with prediabetes as determined by an HbA1c value ≥5.7% and ≤6.4% or a self-reported history of gestational diabetes with an HbA1c <6.5% and/or casual capillary blood glucose (CCBG) <199 mg/dL on weight and metabolic regulation compared with a self-initiated program developed by the National Diabetes Education Program over a 12-month study period. This continuation study assessed outcomes at 18 and 24 months and also evaluated cost effectiveness at 12 and 24 months from a third-party payer perspective. Since this study used a cross over design in which control subjects were provided access to the WW program from 12-24 months, they were no longer randomized.
Results:Intervention participants lost significantly more weight than the controls both at 18 (-5.1% vs -1.8%, p ≤ .008)-and 24-months (-4.5% vs -1.8%, p ≤.032 ). Although both groups showed some improvement in CVD risk factors, the only significant difference between groups was that WW participants had greater reductions than controls in HbA1c at both 18 (-0.27 vs-0.17; p=.03) and 24 months (-0.3 vs -0.2; p=.04). Converting the weight loss into quality adjusted life years saved (QALYs) yielded an incremental cost effectiveness ratio (ICER) of $19,034 per QALY gained for the intervention. Sensitivity analyses showed the ICER was well below commonly accepted thresholds for cost effectiveness.
Conclusion:These data suggest that evidence-based, widely available weight management programs have the potential to cost effectively improve health outcomes for patients with prediabetes. Given their affordability and scalability, increasing access could result in a significant public health impact.